INDUSTRY OVERVIEW
🏭
Pharmaceuticals Major
MOST VOLATILE
Accuracy (30D)
0%
0 recent eventsGap PnL (Fix)
0
$100 baseGap Balance
0
CompoundPost PnL (Fix)
0
$100 basePost Bal
0
Compound📈 Group Equity Curve
Cumulative performance based on a $100 fixed bet per earnings event.
🧠 AI Sentiment
🔒
Locked
⏳ Next Opportunities in this Group
| Asset | Date | Timing | Action |
|---|---|---|---|
![]() $CAMX.ST Camurus AB | Jul 15, 2026 | After Close | PREVIEW → |
![]() $SOBI.ST Swedish Orphan Biovitrum AB | Jul 16, 2026 | After Close | PREVIEW → |
![]() $ORNBV.HE Orion Oyj Class B | Jul 17, 2026 | After Close | PREVIEW → |
![]() $ALM.MC Laboratorios Almirall SA | Jul 24, 2026 | After Close | PREVIEW → |
![]() $2359.HK WuXi AppTec Co Ltd | Jul 27, 2026 | After Close | PREVIEW → |
🏢 Group Constituents List
| Asset ↕ | Events ↕ | Win Rate 🔒 | Net PnL 🔒 |
|---|---|---|---|
VRDN
Viridian Therapeutics Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
NOVO-B.CO
Novo Nordisk B A/S
|
3 |
88%
🔒
|
+$5000
🔒
|
RPRX
Royalty Pharma PLC
|
3 |
88%
🔒
|
+$5000
🔒
|
CAMX.ST
Camurus AB
|
3 |
88%
🔒
|
+$5000
🔒
|
AZN.L
AstraZeneca
|
3 |
88%
🔒
|
+$5000
🔒
|
ZYME
Zymeworks Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
PRQR
ProQR Therapeutics NV
|
3 |
88%
🔒
|
+$5000
🔒
|
PBYI
Puma Biotechnology Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
ONC
BeiGene Ltd-ADR
|
3 |
88%
🔒
|
+$5000
🔒
|
NKTR
Nektar Therapeutics
|
3 |
88%
🔒
|
+$5000
🔒
|
LXRX
Lexicon Pharmaceuticals I
|
3 |
88%
🔒
|
+$5000
🔒
|
GPCR
Structure Therapeutics In
|
3 |
88%
🔒
|
+$5000
🔒
|
|
ESP
ESPR
Esperion Therapeutics Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
DFTX
Definium Therapeutics Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
CTMX
CytomX Therapeutics Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
CRNX
Crinetics Pharmaceuticals
|
3 |
88%
🔒
|
+$5000
🔒
|
CHRS
Coherus Biosciences Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
CGEM
Cullinan Oncology Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
AMLX
Amylyx Pharmaceuticals In
|
3 |
88%
🔒
|
+$5000
🔒
|
ACRS
Aclaris Therapeutics Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
STRO
Sutro Biopharma Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
RGNX
REGENXBIO Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
OKUR
OnKure Therapeutics Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
LPCN
Lipocine Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
GHRS
GH Research PLC
|
3 |
88%
🔒
|
+$5000
🔒
|
ETON
Eton Pharmaceuticals Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
AZN
AstraZeneca PLC ADR
|
3 |
88%
🔒
|
+$5000
🔒
|
ATYR
aTyr Pharma Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
IMMX
Immix Biopharma Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
GYRE
Gyre Therapeutics Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
CLLS
Cellectis SA-ADR
|
3 |
88%
🔒
|
+$5000
🔒
|
TNXP
Tonix Pharmaceuticals Hol
|
3 |
88%
🔒
|
+$5000
🔒
|
HROW
Harrow Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
OLMA
Olema Pharmaceuticals Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
IRWD
Ironwood Pharmaceuticals
|
3 |
88%
🔒
|
+$5000
🔒
|
AKBA
Akebia Therapeutics Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
TNYA
Tenaya Therapeutics Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
TBPH
Theravance Biopharma Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
SPRY
ARS Pharmaceuticals Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
INO
Inovio Pharmaceuticals In
|
3 |
88%
🔒
|
+$5000
🔒
|
BLTE
Belite Bio Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
BHVN
Biohaven Ltd
|
3 |
88%
🔒
|
+$5000
🔒
|
ARCT
Arcturus Therapeutics Hol
|
3 |
88%
🔒
|
+$5000
🔒
|
ANNX
Annexon Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
BAYN.DE
Bayer AG
|
3 |
88%
🔒
|
+$5000
🔒
|
CRBP
Corbus Pharmaceuticals Ho
|
3 |
88%
🔒
|
+$5000
🔒
|
ABOS
Acumen Pharmaceuticals In
|
3 |
88%
🔒
|
+$5000
🔒
|
SVRA
Savara Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
OVID
Ovid Therapeutics Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
MIST
Milestone Pharmaceuticals
|
3 |
88%
🔒
|
+$5000
🔒
|
MGNX
MacroGenics Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
KRRO
Korro Bio Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
IRD
Opus Genetics Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
IMRX
Immuneering Corporation
|
3 |
88%
🔒
|
+$5000
🔒
|
ERAS
Erasca Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
DERM
Journey Medical Corp
|
3 |
88%
🔒
|
+$5000
🔒
|
AUTL
Autolus Therapeu
|
3 |
88%
🔒
|
+$5000
🔒
|
ASND
Ascendis Pharma-ADR
|
3 |
88%
🔒
|
+$5000
🔒
|
ANVS
Annovis Bio
|
3 |
88%
🔒
|
+$5000
🔒
|
ANTX
AN2 Therapeutics Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
ABEO
Abeona Therapeutics Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
ALMS
Alumis Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
SGMT
Sagimet Biosciences Inc-A
|
3 |
88%
🔒
|
+$5000
🔒
|
RVPH
Reviva Pharmaceuticals Ho
|
3 |
88%
🔒
|
+$5000
🔒
|
PLX
Protalix Biotherapeutics
|
3 |
88%
🔒
|
+$5000
🔒
|
PDSB
PDS Biotechnology Corpora
|
3 |
88%
🔒
|
+$5000
🔒
|
ORIC
ORIC Pharmaceuticals Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
OMER
Omeros Corp
|
3 |
88%
🔒
|
+$5000
🔒
|
IMUX
Immunic Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
GRCE
Grace Therapeutics Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
AYTU
Aytu BioScience Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
ABUS
Arbutus Biopharma Corp
|
3 |
88%
🔒
|
+$5000
🔒
|
COCP
Cocrystal Pharma Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
ATNM
Actinium Pharmaceuticals
|
3 |
88%
🔒
|
+$5000
🔒
|
ENTA
Enanta Pharmaceuticals In
|
3 |
88%
🔒
|
+$5000
🔒
|
IMTX
Immatics NV
|
3 |
88%
🔒
|
+$5000
🔒
|
AIM
AIM ImmunoTech Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
VERU
Veru Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
NBP
NovaBridge Biosciences
|
3 |
88%
🔒
|
+$5000
🔒
|
VYNE
VYNE Therapeutics INC
|
2 |
88%
🔒
|
+$5000
🔒
|
RZLT
Rezolute Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
MAZE
Maze Therapeutics Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
SNGX
Soligenix Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
REC.MI
Recordati
|
2 |
88%
🔒
|
+$5000
🔒
|
CAPR
Capricor Therapeutics Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
LEGN
Legend Biotech Corporatio
|
2 |
88%
🔒
|
+$5000
🔒
|
AVIR
Atea Pharmaceuticals Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
LYRA
Lyra Therapeutics Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
INDP
Intec Parent Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
ATRA
Atara Biotherapeutics Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
ATAI
AtaiBeckley Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
RLMD
Relmada Therapeutics Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
MRK.DE
MERCK KGAA
|
2 |
88%
🔒
|
+$5000
🔒
|
MBRX
Moleculin Biotech Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
VRCA
Verrica Pharmaceuticals I
|
2 |
88%
🔒
|
+$5000
🔒
|
RGC
Regencell Bioscience Hold
|
2 |
88%
🔒
|
+$5000
🔒
|
ASPI
ASP Isotopes Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
NYKD.OL
Nykode Therapeutics ASA
|
2 |
88%
🔒
|
+$5000
🔒
|
| 2 |
88%
🔒
|
+$5000
🔒
|
|
OTLK
Outlook Therapeutics Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
SNY
Sanofi-ADR
|
2 |
88%
🔒
|
+$5000
🔒
|
SAN.PA
Sanofi
|
2 |
88%
🔒
|
+$5000
🔒
|
NVO
Novo-Nordisk A/S SPONS AD
|
2 |
88%
🔒
|
+$5000
🔒
|
GSK.L
GlaxoSmithKline
|
2 |
88%
🔒
|
+$5000
🔒
|
NVS
Novartis ADR
|
2 |
88%
🔒
|
+$5000
🔒
|
GSK
GlaxoSmithKline plc ADR
|
2 |
88%
🔒
|
+$5000
🔒
|
SOBI.ST
Swedish Orphan Biovitrum
|
2 |
88%
🔒
|
+$5000
🔒
|
OCUL
Ocular Therapeutix Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
VNDA
Vanda Pharmaceuticals Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
VKTX
Viking Therapeutics Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
NVCT
Nuvectis Pharma Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
RARE
Ultragenyx Pharmaceutical
|
2 |
88%
🔒
|
+$5000
🔒
|
AGIO
Agios Pharmaceuticals Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
NAMS
NewAmsterdam Pharma Compa
|
2 |
88%
🔒
|
+$5000
🔒
|
SYRE
Spyre Therapeutics Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
MDGL
Madrigal Pharmaceuticals
|
2 |
88%
🔒
|
+$5000
🔒
|
TVTX
Travere Therapeutics Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
PRAX
Praxis Precision Medicine
|
2 |
88%
🔒
|
+$5000
🔒
|
ARDX
Ardelyx Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
TARS
Tarsus Pharmaceuticals In
|
2 |
88%
🔒
|
+$5000
🔒
|
IBRX
ImmunityBio Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
KNSA
Kiniksa Pharmaceuticals L
|
2 |
88%
🔒
|
+$5000
🔒
|
FULC
Fulcrum Therapeutics Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
MLTX
MoonLake Immunotherapeuti
|
2 |
88%
🔒
|
+$5000
🔒
|
MIRM
Mirum Pharmaceuticals Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
IONS
Ionis Pharmaceuticals
|
2 |
88%
🔒
|
+$5000
🔒
|
ARQT
Arcutis Biotherapeutics I
|
2 |
88%
🔒
|
+$5000
🔒
|
RYTM
Rhythm Pharmaceuticals In
|
2 |
88%
🔒
|
+$5000
🔒
|
NUVL
Nuvalent Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
MNKD
MannKind Corp
|
2 |
88%
🔒
|
+$5000
🔒
|
XENE
Xenon Pharmaceuticals Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
PHAT
Phathom Pharmaceuticals I
|
2 |
88%
🔒
|
+$5000
🔒
|
EBS
Emergent BioSolutions Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
RIGL
Rigel Pharmaceuticals Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
EOLS
Evolus Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
OCGN
Ocugen Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
EYPT
EyePoint Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
SCYX
Scynexis Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
KROS
Keros Therapeutics Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
AQST
Aquestive Therapeutics In
|
2 |
88%
🔒
|
+$5000
🔒
|
NXTC
NextCure Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
LQDA
Liquidia Corporation
|
2 |
88%
🔒
|
+$5000
🔒
|
CMPX
Compass Therapeutics Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
ZVRA
Zevra Therapeutics Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
NERV
Minerva Neurosciences Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
CRVS
Corvus Pharmaceuticals In
|
2 |
88%
🔒
|
+$5000
🔒
|
ACET
Adicet Bio Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
LFCR
Lifecore Biomedical Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
GOSS
Gossamer Bio Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
BCYC
Bicycle Therapeutics plc
|
2 |
88%
🔒
|
+$5000
🔒
|
GNLX
Genelux Corporation
|
2 |
88%
🔒
|
+$5000
🔒
|
2359.HK
WuXi AppTec Co Ltd
|
2 |
88%
🔒
|
+$5000
🔒
|
LENZ
LENZ Therapeutics Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
BMEA
Biomea Fusion Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
HOWL
Werewolf Therapeutics Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
TPST
Tempest Therapeutics Inc
|
2 |
88%
🔒
|
+$5000
🔒
|
3759.HK
Pharmaron Beijing Co Ltd
|
2 |
88%
🔒
|
+$5000
🔒
|
| 2 |
88%
🔒
|
+$5000
🔒
|
|
CDT
CDT Equity Inc
|
1 |
88%
🔒
|
+$5000
🔒
|
JAGX
Jaguar Health Inc
|
1 |
88%
🔒
|
+$5000
🔒
|
KALA
Kala Bio Inc
|
1 |
88%
🔒
|
+$5000
🔒
|
ORNBV.HE
Orion Oyj Class B
|
1 |
88%
🔒
|
+$5000
🔒
|
HLN
Haleon PLC-ADR
|
1 |
88%
🔒
|
+$5000
🔒
|
UCB.BR
UCB SA
|
1 |
88%
🔒
|
+$5000
🔒
|
ONCIN.OL
Oncoinvent ASA
|
1 |
88%
🔒
|
+$5000
🔒
|
GRF.MC
Grifols SA
|
1 |
88%
🔒
|
+$5000
🔒
|
FARN.L
Faron Pharmaceuticals Oy
|
1 |
88%
🔒
|
+$5000
🔒
|
HCM.L
Hutchmed (China) Limited
|
1 |
88%
🔒
|
+$5000
🔒
|
HCM
HUTCHMED China Limited
|
1 |
88%
🔒
|
+$5000
🔒
|
DBV.PA
DBV Technologies
|
1 |
88%
🔒
|
+$5000
🔒
|
HYL.BR
Hyloris Pharmaceuticals S
|
1 |
88%
🔒
|
+$5000
🔒
|
9926.HK
Akeso Inc
|
1 |
88%
🔒
|
+$5000
🔒
|
NANO.PA
Nanobiotix SA
|
1 |
88%
🔒
|
+$5000
🔒
|
FYB.DE
FORMYCON AG
|
1 |
88%
🔒
|
+$5000
🔒
|
VISTN.OL
Vistin Pharma ASA
|
1 |
88%
🔒
|
+$5000
🔒
|
IDYA
IDEAYA Biosciences Inc
|
1 |
88%
🔒
|
+$5000
🔒
|
PTN
Palatin Technologies Inc
|
1 |
88%
🔒
|
+$5000
🔒
|
IPH.PA
Innate Pharma SA
|
1 |
88%
🔒
|
+$5000
🔒
|
DMP.DE
DERMAPHARM HOLDING SE
|
1 |
88%
🔒
|
+$5000
🔒
|
FRMM
Forum Markets Inc
|
1 |
88%
🔒
|
+$5000
🔒
|
LYTIX.OL
LYTIX BIOPHARMA ASA
|
1 |
88%
🔒
|
+$5000
🔒
|
MEDCL.PA
Medincell SA
|
1 |
88%
🔒
|
+$5000
🔒
|
🔒 The historical Win Rate and precise Net PnL of each constituent are strictly reserved for PRO Members.
Unlock Premium Metrics




